USD 0.08
(14.29%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 32.5 Thousand CAD | -18.75% |
2022 | 40 Thousand CAD | 0.0% |
2021 | 40 Thousand CAD | 0.0% |
2020 | 40 Thousand CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | -100.0% |
2015 | 81.31 Thousand CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | - CAD | -100.0% |
2024 Q2 | 32.5 Thousand CAD | 0.0% |
2024 Q1 | 32.5 Thousand CAD | 0.0% |
2023 Q1 | 40 Thousand CAD | 0.0% |
2023 Q2 | 40 Thousand CAD | 0.0% |
2023 Q3 | 40 Thousand CAD | 0.0% |
2023 FY | 32.5 Thousand CAD | -18.75% |
2023 Q4 | 32.5 Thousand CAD | -18.75% |
2022 Q3 | 40 Thousand CAD | 0.0% |
2022 FY | 40 Thousand CAD | 0.0% |
2022 Q1 | 40 Thousand CAD | 0.0% |
2022 Q2 | 40 Thousand CAD | 0.0% |
2022 Q4 | 40 Thousand CAD | 0.0% |
2021 FY | 40 Thousand CAD | 0.0% |
2021 Q1 | 40 Thousand CAD | 0.0% |
2021 Q2 | 40 Thousand CAD | 0.0% |
2021 Q3 | 40 Thousand CAD | 0.0% |
2021 Q4 | 40 Thousand CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 FY | 40 Thousand CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q4 | 40 Thousand CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | -100.0% |
2016 Q1 | - CAD | -100.0% |
2015 Q4 | 81.31 Thousand CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 FY | 81.31 Thousand CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
American Bio Medica Corporation | 6000.00 USD | -441.667% |
Arrayit Corporation | - USD | -Infinity% |
Atlantic International Corp. | 1.29 Million USD | 97.495% |
Biocept, Inc. | 10.37 Million USD | 99.687% |
Bioqual, Inc. | - USD | -Infinity% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 51.3 Million USD | 99.937% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 99.947% |
HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | 94.051% |
iMD Companies, Inc. | 1.1 Million USD | 97.055% |
IDenta Corp. | 428.17 Thousand USD | 92.41% |
Interpace Biosciences, Inc. | 4.24 Million USD | 99.234% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | - USD | -Infinity% |
Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 278 Thousand USD | 88.309% |
NovelStem International Corp. | 3.32 Million USD | 99.022% |
Optigenex Inc. | 4.42 Million USD | 99.266% |
PharmChem, Inc. | - USD | -Infinity% |
Proteome Sciences plc | 1.63 Million USD | 98.007% |
Response Genetics, Inc | 4.91 Million USD | 99.339% |
Rennova Health, Inc. | 359.19 Thousand USD | 90.952% |
RushNet, Inc. | 4.25 Million USD | 99.236% |
ScreenPro Security Inc. | 249.05 Thousand USD | 86.95% |
Stella Diagnostics Inc. | 798.44 Thousand USD | 95.93% |
StageZero Life Sciences Ltd. | 576.38 Thousand USD | 94.361% |
Todos Medical Ltd. | 33 Million USD | 99.902% |